 |
William P. ('Bill') Reddick, M. H. A. Chief Financial Officer Mr. Reddick held various management positions with Arthur Andersen and The Hospital Authority of Fulton County, Georgia. From 1994-2005, Mr. Reddick was Co-founder, Healthcare Analyst, and the Director of Research for Masters Capital Management, a hedge fund. During that time Mr. Reddick worked extensively with public and private biotechnology and medical device companies. Mr. Reddick is a graduate of Eastern Kentucky University (B.B.A.) and the University of Houston (M.H.A.). Since 2005 Mr. Reddick has been the CFO of Celtaxsys and is a member of the Board of Directors. |
 |
Eric Springman, Ph.D. Chief Scientific Officer Dr Springman is the former Senior Director and founder of the Biology Department of Locus Pharmaceuticals where he led the Company’s initial IND. Prior to that, he was Acting Head of Arthritis Therapy at Roche Pharmaceuticals in Palo Alto, CA.and at Arris/Axys Pharmaceuticals in South San Francisco, CA, where he was co-leader of the partnered project resulting in Merck's Phase III drug candidate, odanacatib In 2007, Dr. Springman was appointed by Governor Edward Rendell to the Pennsylvania Drug, Device & Cosmetics Board. |
 |
Ralph D. Grosswald, M.P.H. Director of Operations Mr. Grosswald was a Founder, Director of Operations and Sr. Project Manager for GMP Companies, Inc. where he managed projects for the commercially available LifeSync© Wireless ECG System and the Eyepass© glaucoma drainage device. He was the Director of Research for National Healthcare Network, a managed care network of 40 cardiovascular centers of excellence. Ralph was also a Clinical Trial Coordinator for Emory University School of Medicine. |